Harvard Pulmonary and Critical Care Medicine 2025

 56 videos + 49 pdfs, size: 18.8 GB

Comprehensive Updates for State-of-the-Art Care: Evaluation, Diagnosis, Treatment, Procedures, and Challenging Cases

Pulmonary and Critical Care Medicine will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies. The 2025 program will be highly interactive, providing opportunities throughout the program to pose questions online to nationally and internationally recognized leaders in their respective areas of pulmonary and critical care medicine.

OVERVIEW

This comprehensive course provides education and updates to optimize your care of patients with:

• IPF
• ARDS
• Sarcoidosis
• Lung transplantation
• Bronchiectasis
• Cystic fibrosis
• Lung nodules
• Lung cancer
• Sepsis
• Pleural disease
• Pneumonia
• Tuberculosis
• Thromboembolism
• Chronic cough
• COPD

• Asthma
• Occupational and environmental lung disease
• Interstitial lung disease
• GERD
• Neurologic issues in the ICU
• Sleep-disordered breathing
• Post-acute sequelae of COVID-19
• Surgical emergencies
• Atypical mycobacterial disease
• Pulmonary hypertension
• Cardiopulmonary disorders
• Complications from cardiac arrest
• Hypersensitivity pneumonitis
• Acute respiratory failure

REASONS TO ATTEND IN 2025

All sessions are led by master clinicians who deliver information in inspiring and entertaining ways, and provide specific recommendations to incorporate the latest updates into your practice. Education covers:

• The most current guidelines for treating sepsis
• Evidence-based treatment of ARDS
• State of the art in interventional pulmonology
• High-flow oxygen therapy for respiratory failure
• Updates on biologics in asthma and other lung disease
• New concepts in the use of vasopressors in septic shock
• New drugs and combinations in pulmonary hypertension
• New evidence on sedation, analgesia, and early mobility in the ICU
• Point-of-care pulmonary ultrasound in the intensive care unit
• Lung microbiome: emerging implications for lung health
• Emerging evidence for targeted temperature management
• Evaluating occupational and environmental lung disease
• Steroid-sparing agents for interstitial lung disease
• Pulmonary embolus: the latest treatment strategies
• State-of-the-art management of the critically ill patient
• Guidance to conduct end-of-life discussions
• Updates in pulmonary pathology
• New treatment options in cystic fibrosis
• Handling neurologic and surgical emergencies in the medical ICU
• New approaches that improve outcomes for patients with unexplained chronic cough

Participants also have access to expanded question and answer sessions with faculty throughout the program, which promotes discussion of the complexity of real-world care.

Optional Half-Day Program
(No additional fees apply)

Sleep Medicine for Pulmonologists

This sleep medicine program provides pulmonologists the opportunity to learn about recent advances in Sleep Medicine and how they impact clinical practice.

Offered on Friday afternoon, May 2, participants of Pulmonology and Critical Care Medicine 2025 can participate in this half-day program at no additional cost.

Highlights of this practical, interactive educational experience include:

• Updates for diagnosis and management of sleep-disordered breathing
• State-of-the-art management algorithms
• New technologies vs. the “gold standard” polysomnogram
• Reimbursement and telemedicine
• Improved adherence to therapy

Participants will leave with specific recommendations to improve the clinical care of patients with sleep disorders.

OPTIMIZED FOR REMOTE EDUCATION

The 2025 program has been enhanced for distance learning. In addition to being live streamed, all sessions will be recorded and made available to participants for online viewing for 90 days after the end of the course.

Topics:

• Day 1 Beyond Cystic Fibrosis Diagnosis and Management of Non-CF Bronchiectasis.mp4
  Day 1 Beyond Cystic Fibrosis Diagnosis and Management of Non-CF Bronchiectasis.pdf
  Day 1 Cystic Fibrosis Understanding CFTR and New Treatment.mp4
  Day 1 Cystic Fibrosis Understanding CFTR and New Treatment.pdf
  Day 1 Diagnosis and Management of IPF When, Why, and How to Use the Newest Drugs.mp4
  Day 1 Diagnosis and Management of IPF When, Why, and How to Use the Newest Drugs.pdf
  Day 1 Evolving Concepts in the Diagnosis and Management of Connective Tissue Disease-Associated ILD.mp4
  Day 1 Evolving Concepts in the Diagnosis and Management of Connective Tissue Disease-Associated ILD.pdf
  Day 1 Exercise and Cardiopulmonary Disorders Indications and Interpretation.mp4
  Day 1 Exercise and Cardiopulmonary Disorders Indications and Interpretation.pdf
  Day 1 GERD in Pulmonology.mp4
  Day 1 GERD in Pulmonology.pdf
  Day 1 Hypersensitivity Pneumonitis Pigeons, Farmers, and Hot Tubs, Oh My.mp4
  Day 1 Hypersensitivity Pneumonitis Pigeons, Farmers, and Hot Tubs, Oh My.pdf
  Day 1 Looking Deeper Patterns and Insights from Chest Radiology.mp4
  Day 1 Looking Deeper Patterns and Insights from Chest Radiology.pptx
  Day 1 Lung Transplantation 2025 Referral, Patient Selection, Lung Allocation, and COVID.mp4
  Day 1 Lung Transplantation 2025 Referral, Patient Selection, Lung Allocation, and COVID.pdf
  Day 1 Pulmonary Pathology Interstitial Lung Disease.mp4
  Day 1 Pulmonary Pathology Interstitial Lung Disease.pdf
  Day 1 Q & A Session with Speakers 1.mp4
  Day 1 Q & A Session with Speakers 2.mp4
  Day 1 Treatment Challenges of Pulmonary Sarcoidosis.mp4
  Day 1 Treatment Challenges of Pulmonary Sarcoidosis.pdf
  Day 2 After the ICU Post-ICU Care Syndrome and Recovery.mp4
  Day 2 After the ICU Post-ICU Care Syndrome and Recovery.pdf
  Day 2 Approach to Empiric Antibiotics in the ICU.mp4
  Day 2 Approach to Empiric Antibiotics in the ICU.pdf
  Day 2 Approach to the Immunocompromised Critically Ill Patient.mp4
  Day 2 Approach to the Immunocompromised Critically Ill Patient.pdf
  Day 2 ARDS State-of-the-Art Strategies to Protect the Lung.mp4
  Day 2 ARDS State-of-the-Art Strategies to Protect the Lung.pdf
  Day 2 Fluid Responsiveness.mp4
  Day 2 Fluid Responsiveness.pdf
  Day 2 From Ancient Egypt to Balanced Crystalloids Medicine’s Attempts to Manage Sepsis.mp4
  Day 2 From Ancient Egypt to Balanced Crystalloids Medicine’s Attempts to Manage Sepsis.pdf
  Day 2 Noninvasive Respiratory Support for Acute Respiratory Failure Less May NOT Be Best.mp4
  Day 2 Noninvasive Respiratory Support for Acute Respiratory Failure Less May NOT Be Best.pdf
  Day 2 Novel Ventilator Modes The Hype and the Reality.mp4
  Day 2 Novel Ventilator Modes The Hype and the Reality.pdf
  Day 2 Q & A with Speakers 1.mp4
  Day 2 Q & A with Speakers 2.mp4
  Day 2 Renal Replacement Therapy in the ICU What and When to Start (or Not).mp4
  Day 2 Renal Replacement Therapy in the ICU What and When to Start (or Not).pdf
  Day 2 Sedation, Analgesia, and Early Mobility The State of the Art in 2025.mp4
  Day 2 Sedation, Analgesia, and Early Mobility The State of the Art in 2025.pdf
  Day 2 Vasopressors in Septic Shock Old Friends and New.mp4
  Day 2 Vasopressors in Septic Shock Old Friends and New.pdf
  Day 3 Advanced Cardiac Support in the ICU.mp4
  Day 3 Advanced Cardiac Support in the ICU.pdf
  Day 3 Common Neurologic Issues in the ICU.mp4
  Day 3 Common Neurologic Issues in the ICU.pdf
  Day 3 New Approaches to the Unexplained Chronic Cough.mp4
  Day 3 New Approaches to the Unexplained Chronic Cough.pdf
  Day 3 Occupational and Environmental Lung Disease.mp4
  Day 3 Occupational and Environmental Lung Disease.pdf
  Day 3 Palliative Care in Advanced Lung Disease.mp4
  Day 3 Palliative Care in Advanced Lung Disease.pdf
  Day 3 Pneumonia (Community and Hospital Acquired) Using the Newest Guidelines to Provide Evidence-Based Care.mp4
  Day 3 Pneumonia (Community and Hospital Acquired) Using the Newest Guidelines to Provide Evidence-Based Care.pdf
  Day 3 Point-of-Care Ultrasound in the Intensive Care Unit.mp4
  Day 3 Point-of-Care Ultrasound in the Intensive Care Unit.pdf
  Day 3 Prognosis and Uncertainty in the ICU.mp4
  Day 3 Q & A with Speakers 1.mp4
  Day 3 Q & A with Speakers 2.mp4
  Day 3 Surgical Emergencies in the Medical ICU.mp4
  Day 3 Surgical Emergencies in the Medical ICU.pdf
  Day 3 The Microbiome and Lung Disease.mp4
  Day 3 The Microbiome and Lung Disease.pdf
  Day 3 TTM and Neuroprognostication After Cardiac Arrest.mp4
  Day 3 TTM and Neuroprognostication After Cardiac Arrest.pdf
  Day 4 A Strategic Approach to the Management of Pulmonary Nodules.pdf
  Day 4 Aspergillus Lung Disease.mp4
  Day 4 Aspergillus Lung Disease.pdf
  Day 4 Asthma What’s New in 2025.mp4
  Day 4 Asthma What’s New in 2025.pdf
  Day 4 COPD 2025.mp4
  Day 4 COPD 2025.pdf
  Day 4 Interventional Bronchoscopy in COPD Valves, Coils, and Beyond.mp4
  Day 4 Interventional Pulmonology in 2025.mp4
  Day 4 New Therapeutics in Lung Disease The Age of Immunotherapy.mp4
  Day 4 New Therapeutics in Lung Disease The Age of Immunotherapy.pdf
  Day 4 Nontuberculous Mycobacterial Disease Navigating the Labyrinth.mp4
  Day 4 Nontuberculous Mycobacterial Disease Navigating the Labyrinth.pdf
  Day 4 Pleural Disease 2025 Updates.mp4
  Day 4 Pleural Disease 2025 Updates.pdf
  Day 4 Q & A with Speakers 1.mp4
  Day 4 Q & A with Speakers 2.mp4
  Day 4 Treatment of Non-Small Cell Lung Cancer Traditional Chemotherapy, Targeted Therapy, and Immunotherapies.mp4
  Day 4 Treatment of Non-Small Cell Lung Cancer Traditional Chemotherapy, Targeted Therapy, and Immunotherapies.pdf
  Day 4 Tuberculosis in 2025.mp4
  Day 4 Tuberculosis in 2025.pdf
  Day 5 Complex Sleep Apnea 2025.pdf
  Day 5 Noninvasive Ventilation.pdf
  Day 5 Obstructive Sleep Apnea.pdf
  Day 5 Pulmonary Embolism An Update.mp4
  Day 5 Pulmonary Hypertension Categorization and Evaluation.mp4
  Day 5 Pulmonary Hypertension Management.pdf
  Day 5 Sleep Diagnostics.pdf
  Day 5 Thrombotic Mechanisms and Antithrombotic Agents How Do the New Oral Agents Fit in 2025.mp4
  Day 5 Thrombotic Mechanisms and Antithrombotic Agents How Do the New Oral Agents Fit in 2025.pdf
  Day 5 Vasculitis and ANCA.mp4
  Day 5 Vasculitis and ANCA.pdf
  Day 5.mp4
  Pulmonary Schedule.pdf